Home > Current issue > JPPR 2005 > JPPR September 2005

Volume 35, No. 3, September 2005


Extemporaneous Compounding
Richard J Prankerd, 173

Closing the Gap between Evidence and Practice
Luke Bereznicki, Shane Jackson, Gregory Peterson, 173

Hospital Pharmacy Training Ground of Consultant Pharmacists for the Future
Jeff Hughes, 175


Pharmacist Prescribing: Views of Australian Hospital Pharmacists (members only)
Carissa A Hanes, Beata V Bajorek, 178

Extemporaneous Isoniazid Mixture: Stability Implications (members only)
Alison Haywood, Martina Mangan, Gary Grant, Beverley Glass, 181

Paediatric Severe Community-Acquired Pneumonia in India (members only)
Mallik V Angalakuditi, V Bruce Sunderland, 183

Emergence of Adverse Reactions to Tramadol in Children and Adolescents at a Paediatric Hospital (members only)
Gisela Santa Juliana, Thirza Titchen, Noel Cranswick, 187

Identification of Medication Errors by Nurses During a Simulated Ward, Medication Safety Orientation Program (members only)
Ian D Coombes, Alison CY Heel, Danielle A Stowasser, Carol M Reid, Amanda Henderson, Charles A Mitchell, 190

Pharmacy Practice

Oral Antineoplastic Chemotherapy (members only)
Peter J Gilbar, Christine V Carrington, 195

European Forum on Quality Improvement in Health Care (members only)
Melita A Van de Vreede, 199

SHPA Grants Program Does it Meet Members Needs? (members only)
Margaret J Duguid, Karen O Leary, 201

Experiencing Pharmacy Practice in Rural Tanzania (members only)
Gina B McLachlan, 205

Practice Developments for Hospital Technicians in the UK (members only)
Marysia B Janczak, 207

Assessment Drives Learning (members only)
Paul A Tait, 211


Thiopurines for Inflammatory Bowel Disease: Role of Pharmacogenetics (members only)
Asmar FY Al Hadithy, Mark Naunton, Jacobus RBJ Brouwers, 213

Case Reports

Hypothermia Associated with Olanzapine (members only)
Kwok-Pui Jody Chu, Karin Nyfort-Hansen, 216

Renal Failure and Acute Interstitial Nephritis Associated with NSAIDs (members only)
Lisa Ho, Andy KH Lim, Francine Tanner, 219

Systemic Absorption of Low-Dose Oral Vancomycin (members only)
Deas M Brouwer, Carmela E Corallo, John Coutsouvelis, 222

Medication Safety

Medication Safety Series
Edited by Penny Thornton, 224

Geriatric Therapeutics

Pharmacological Treatment of Challenging Neuropsychiatric Symptoms of Dementia
Michael C Woodward, 228


Literature summaries of the latest developments in pharmacy practice and therapeutics (members only), 235

Other Sections

Letters to the Editor, 244

Medication safety and patient participation: pharmacist, emergency department and beyond. Jenny Blennerhassett, Linda Graudins, 244
Amgen International Pharmacy Preceptorship. Jude Lees, 244-5
Folic acid for methotrexate-induced neutropenia. Anil Verma, 245
Warfarin information on discharge summaries. Bradley Thomas, Luigi Gaetani, 245-8
Experience of the Master of Clinical Pharmacy degree. Katherine J Graham, 248
Heart lung transplant symposium. Luke Mannix, 248-9

SHPA Research and Development Grants Program, 204, 218
National Competencies for the Prescribing of Medicines (SHPA Position Statement) (members only), 246
Advertisers Index, 249

Article Reprints

Copies of articles from the Journal of Pharmacy Practice and Research and The Australian Journal of Hospital Pharmacy can be ordered from the National Library of Australia. You can order online at the NLA website by providing the citation and credit card details.

Member Login

Forgotten your login details?

Join SHPA.
Buy online courses

  • Update on Medicinal Cannabis
  • As medicinal cannabis products become more accessible and prescribed, hospital pharmacists will need to be cognisant of how these medicines are handled and the federal and jurisdictional requirements they will need to comply with. SHPA is committed to keeping abreast of this emerging therapy, and below is a snapshot on where medicinal cannabis is at presently in Australia.
  • SHPA Will Take Action to Support Continuation of Advanced Practice Recognition
  • The Society of Hospital Pharmacists of Australia (SHPA) CEO, Kristin Michaels, responding to today's announcement by the Australian Pharmacy Council to end the National Credentialing of Advanced Practice Pharmacists, said the Society will continue to strongly support Advanced Practice.
  • SHPA Vision for the Future of Pharmacy is Winning Strong Support
  • Professor Michael Dooley said today the Society has received over 30 applications from hospitals and health services for the SHPA Residency Program inaugural intake commencing in 2017.


    Member Login


    Logging Into SHPA Website.